Does vitamin D promote immune tolerance and lower thyroid autoantibodies in Hashimoto's thyroiditis?

Vitamin D acts as a potent immunomodulator that plays a crucial role in maintaining self-tolerance and mitigating autoimmune thyroid diseases such as Hashimoto's thyroiditis.

Mechanistic pathways of immune tolerance

• Genomic reprogramming of T-cells: Active vitamin D binds to the nuclear vitamin D receptor (VDR) and retinoid X receptor (RXR) complex to alter T-cell transcription. This genomic signaling downregulates pro-inflammatory Th1 and Th17 pathways, directly repressing key cytokines such as interleukin-17 (IL-17A), interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α).
• Treg induction and stabilization: VDR activation genomicly induces and stabilizes FoxP3, the master transcription factor for regulatory T cells (Tregs). It also promotes a tolerogenic dendritic cell phenotype characterized by reduced IL-12 and enhanced IL-10 production, shifting the immune environment toward homeostatic tolerance.

Clinical evidence in Hashimoto's thyroiditis

• Inverse correlation with autoantibodies: Large observational and cross-sectional cohorts demonstrate that lower serum 25-hydroxyvitamin D [25(OH)D] levels are consistently associated with higher thyroid peroxidase antibody (TPOAb) titers and, to a lesser extent, thyroglobulin antibodies (TgAb).
• Efficacy of clinical supplementation: Meta-analyses of randomized controlled trials (RCTs) confirm that correcting deficiency through oral vitamin D supplementation significantly reduces both TPOAb and TgAb titers. These reduction benefits are most pronounced with continuous daily dosing regimens sustained for 3 to 6 months. Because these autoantibodies serve as clinical biomarkers of thyroid parenchymal destruction, lowering their levels indicates a reduction in active disease severity.

Bottom line

• Vitamin D directly promotes immune tolerance by suppressing inflammatory Th1/Th17 pathways and driving FoxP3+ regulatory T-cell stabilization; clinically, correcting vitamin D deficiency significantly reduces thyroid autoantibody titers, providing an effective secondary strategy to help control autoimmune activity in Hashimoto's thyroiditis.